NewEdge Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338 | Hold |
26
| – | – | ﹤0.01% | 3842 |
|
|
2025
Q1 | $275 | Hold |
26
| – | – | ﹤0.01% | 3775 |
|
|
2024
Q4 | $441 | Hold |
26
| – | – | ﹤0.01% | 3672 |
|
|
2024
Q3 | $603 | Hold |
26
| – | – | ﹤0.01% | 3585 |
|
|
2024
Q2 | $633 | Hold |
26
| – | – | ﹤0.01% | 3540 |
|
|
2024
Q1 | $878 | Hold |
26
| – | – | ﹤0.01% | 3522 |
|
|
2023
Q4 | $820 | Hold |
26
| – | – | ﹤0.01% | 3489 |
|
|
2023
Q3 | $664 | Hold |
26
| – | – | ﹤0.01% | 3221 |
|
|
2023
Q2 | $746 | Hold |
26
| – | – | ﹤0.01% | 3283 |
|
|
2023
Q1 | $623 | Hold |
26
| – | – | ﹤0.01% | 3218 |
|
|
2022
Q4 | $0 | Buy |
+26
| New | – | ﹤0.01% | 4085 |
|